Guardant Health (NASDAQ:GH) raised its full-year 2026 revenue forecast after third-quarter sales increased 36%, driven by growth in its oncology testing business and demand for its Shield blood-based ...

Guardant Health stock falls 9.1% to $153.43 today, despite a revenue forecast increase and strong third quarter results.

A Caldwell widow spent years sharing her late husband’s pancreatic cancer story. She believes it’s why the man she loves now survived the same disease.

Thompson hit the first game-winner of a 16-year career in overtime against the Clippers, then said he wants a back-to-back ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter ...

Reform called for a pause to "stress test" alternative options ...

Guardant Health Inc (NASDAQ:GH) reported third quarter results that exceeded analyst expectations, but shares tumbled 12% in after-hours trading Thursday as the company raised its free cash flow burn ...

Australian T20 batter Chris Lynn completed a one-month suspension and rehabilitation program following a positive cocaine ...

Bhayshul Tuten owns the top PFF grade among running backs, and if his ankle allows it, a Ravens defense that missed 11 ...

NBA teams have anticipated 2027 to be a down draft cycle for several reasons, chief among them that this year's incoming ...

A Virginia woman's self-awareness helped her detect breast cancer twice. Her story is a powerful reminder to know your body ...

Nasdaq’s November 5 selloff sent the Composite down 5.52%, challenging the assumption that AI infrastructure spending can ...